FAILED
首站-论文投稿智能助手
典型文献
Sequentially immune-induced antibodies could cross-neutralize SARS-CoV-2 variants
文献摘要:
Background : The Omicron (B.1.1.529) SARS- COV- 2 variant has raised serious con-cerns because of its unprecedented rapid rate of spreading and the fact that there are 36 mutations in the spike protein. Since the vaccine-i nduced neutralizing antibody targets are the spike protein, this may lead to the possibility of vaccine-i nduced hu-moral immunity escape.Methods : We measured the neutralizing activity in vitro for Omicron and compared this with wild type (WH- 09) and Delta variants in human and monkey sera from dif-ferent types of immunity. The monkey sera samples were collected at 1 and 3 months post three- dose inactivated (PiCoVacc) and recombinant protein (ZF2001) vaccination. Human sera were collected from 1 month post three- dose inactivated vaccination. Results : In inactivated vaccine sera, at 1/3 months post three- dose, geometric mean titers (GMTs) of neutralization antibody (NAb) against the Omicron variant were 4.9/5.2- fold lower than those of the wild type. In recombinant protein vaccine sera, GMTs of NAb against Omicron were 15.7/8.9- fold lower than those of the wild type. In human sera, at 1 month post three- dose inactivated vaccination, GMTs of NAb against Omicron were 3.1- fold lower than those of the wild type. Conclusion : This study demonstrated that despite a reduction in neutralization titers, cross- neutralizing activity against Omicron and Delta variants was still observed after three doses of inactivated and recombinant protein vaccination.
文献关键词:
作者姓名:
Qi Lv;Shasha Zhou;Feifei Qi;Yaqing Zhang;Fengdi Li;Mingya Liu;Linlin Bao
作者机构:
Beijing Key Laboratory for Animal Models of Emerging and Reemerging Infectious Diseases,NHC Key Laboratory of Human Disease Comparative Medicine,Institute of Laboratory Animal Science,Chinese Academy of Medical Sciences and Comparative Medicine Center,Peking Union Medical College,Beijing,China;National Center of Technology Innovation for Animal Model,Beijing, China
引用格式:
[1]Qi Lv;Shasha Zhou;Feifei Qi;Yaqing Zhang;Fengdi Li;Mingya Liu;Linlin Bao-.Sequentially immune-induced antibodies could cross-neutralize SARS-CoV-2 variants)[J].动物模型与实验医学(英文),2022(01):89-93
A类:
nduced,PiCoVacc,GMTs
B类:
Sequentially,immune,induced,antibodies,could,cross,neutralize,SARS,variants,Background,Omicron,COV,has,raised,serious,con,cerns,because,its,unprecedented,rapid,spreading,fact,that,there,mutations,spike,protein,Since,vaccine,neutralizing,antibody,targets,this,may,lead,possibility,moral,immunity,escape,Methods,We,measured,activity,vitro,compared,wild,WH,Delta,human,monkey,sera,from,dif,ferent,types,samples,were,collected,months,post,three,inactivated,recombinant,ZF2001,vaccination,Human,Results,In,geometric,mean,titers,neutralization,NAb,against,fold,lower,than,those,Conclusion,This,study,demonstrated,despite,reduction,was,still,observed,after,doses
AB值:
0.431888
相似文献
Knowledge about,attitude and acceptance towards,and predictors of intention to receive the COVID-19 vaccine among cancer patients in Eastern China:A cross-sectional survey
Jing Hong;Xiao-wan Xu;Jing Yang;Jing Zheng;Shu-mei Dai;Ju Zhou;Qing-mei Zhang;Yi Ruan;Chang-quan Ling-School of Traditional Chinese Medicine,Naval Medical University,Shanghai 200433,China;Department of Integrative Oncology,Changhai Hospital,Naval Medical University,Shanghai 200433,China;Department of Oncology,The First Affiliated Hospital,Bengbu Medical College,Bengbu 233010,Anhui Province,China;Department of Nursing,Fuyang Cancer Hospital,Fuyang 236000,Anhui Province,China;Department of Cardiac Rehabilitation,Shanghai First Rehabilitation Hospital,Shanghai 200090,China;Department of Radiation Oncology,Anhui Chest Hospital,Hefei 230022,Anhui Province,China;Department of Anesthesiology,Chaohu Hospital,Anhui Medical University,Hefei 238000,Anhui Province,China
A broadly neutralizing human monoclonal antibody against the hemagglutinin of avian influenza virus H7N9
Li Jingxin;Zhang Li;Bao Linlin;Wang Yuxiao;Qiu Lin;Hu Jialei;Tang Rong;Yu Huiyan;Shan Jun;Li Yan;Qin Chuan;Zhu Fengcai-Department for Vaccine Clinical Evaluation, NHC Key Laboratory of Enteric Pathogenic Microbiology, Jlangsu Provincial Center for Diseases Control and Prevention, Nanjing, Jiangsu 210009, China;Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences (CAMS) & Comparative Medicine Center, Peking Union Medical Collage (PUMC); Key Laboratory of Human Disease Comparative Medicine, Ministry of Health, Beijing Key Laboratory for Animal Models of Emerging and Reemerging Infectious Diseases, Beijing 100101, China;Department of Public Health, Southeast University, Nanjing, Jiangsu 210009, China;Shanghai Institute for Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, China
Early assessment of the safety and immunogenicity of a third dose(booster)of COVID-19 immunization in Chinese adults
Yuntao Zhang;Yunkai Yang;Niu Qiao;Xuewei Wang;Ling Ding;Xiujuan Zhu;Yu Liang;Zibo Han;Feng Liu;Xinxin Zhang;Xiaoming Yang-China National Biotec Group Company Limited,Beijing 100024,China;Shanghai Institute of Hematology,State Key Laboratory of Medical Genomics,National Research Center for Translational Medicine at Shanghai,Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine,Shanghai 200025,China;Beijing Institute of Biological Products,China National Biotec Group Company Limited,Beijing 100176,China;National Vaccine and Serum Institute,China National Biotec Group Company Limited,Beijing 101111,China;Department of Infectious Diseases,Research Laboratory of Clinical Virology,Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine,Shanghai 200025,China
Long-term correction of hemorrhagic diathesis in hemophilia A mice by an AAV-delivered hybrid FⅧ composed of the human heavy chain and the rat light chain
Jianhua Mao;Yun Wang;Wei Zhang;Yan Shen;Guowei Zhang;Wenda Xi;Qiang Wang;Zheng Ruan;Jin Wang;Xiaodong Xi-Shanghai Institute of Hematology,State Key Laboratory of Medical Genomics,Collaborative Innovation Center of Hematology,Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine,Shanghai 200025,China;Shanghai Institute of Hematology,State Key Laboratory for Medical Genomics and Department of Hematology,Collaborative Innovation Center of Systems Biomedicine,P?le Sino-Fran?ais des Sciences du Vivant et Genomique,Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine,Shanghai 200025,China;Research Center for Experimental Medicine,Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine,Shanghai 200025,China;The School of Medicine,Hangzhou Normal University,Hangzhou 310036,China;Shanghai Institute of Hypertension,Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine,Shanghai 200025,China
Seroprevalence of influenza viruses in Shandong,Northern China during the COVID-19 pandemic
Chuansong Quan;Zhenjie Zhang;Guoyong Ding;Fengwei Sun;Hengxia Zhao;Qinghua Liu;Chuanmin Ma;Jing Wang;Liang Wang;Wenbo Zhao;Jinjie He;Yu Wang;Qian He;Michael J.Carr;Dayan Wang;Qiang Xiao;Weifeng Shi-Key Laboratory of Etiology and Epidemiology of Emerging Infectious Diseases in Universities of Shandong,Shandong First Medical University&Shandong Academy of Medical Sciences,Taian 271000,China;School of Public Health,Shandong First Medical University&Shandong Academy of Medical Sciences,Jinan 250117,China;The Department of Infectious Disease,The Second Affiliated Hospital of Shandong First Medical University,Taian 271000,China;Clinical Laboratory,The Department of Clinical Laboratory,Boshan District Hospital,Zibo 255200,China;Clinical Laboratory,The Department of Clinical Laboratory,The Second Affiliated Hospital of Shandong First Medical University,Taian 271000,China;The Department of Cancer Center,Taian Tumor Prevention and Treatment Hospital,Taian 271000,China;National Virus Reference Laboratory,School of Medicine,University College Dublin,Dublin 4,Ireland;International Collaboration Unit,International Institute for Zoonosis Control,Hokkaido University,Sapporo,Hokkaido,001-0020,Japan;Chinese National Influenza Center,National Institute for Viral Disease Control and Prevention,Collaboration Innovation Center for Diagnosis and Treatment of Infectious Diseases,Chinese Center for Disease Control and Prevention,Key Laboratory for Medical Virology,National Health and Family Planning Commission,Beijing 102206,China
Sustained over-expression of calpain-2 induces age-dependent dilated cardiomyopathy in mice through aberrant autophagy
Xiao-yun Ji;Dong Zheng;Rui Ni;Jin-xi Wang;Jian-qiang Shao;Zer Vue;Antentor Hinton Jr.;Long-Sheng Song;Guo-Chang Fan;Subrata Chakrabarti;Zhao-liang Su;Tian-qing Peng-International Genome Center,Jiangsu University,Zhenjiang 212013,China;Lawson Health Research Institute,London Health Sciences Centre,London,ON N6A 5W9,Canada;Department of Pathology and Laboratory Medicine,Western University,London,ON N6A 5C1,Canada;Centre of Clinical Laboratory,the First Affiliated Hospital of Soochow University,Suzhou 215006,China;Division of Cardiovascular Medicine,Department of Internal Medicine,Abboud Cardiovascular Research Center,Carver College of Medicine,University of Iowa,Iowa City,IA 52242,USA;CentrallMicroscopy Research Facility,University of Iowa,Iowa City,IA 52242,USA;Department of Molecular Physiology and Biophysics,Vanderbilt University,Nashville,TN 37232,USA;Department of Pharmacology and Systems Physiology,University of Cincinnati College of Medicine,Cincinnati,OH 45267,USA;Department of Medicine,Western University,London,ON N6A 5W9,Canada
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。